Mundipharma
René Sajfrt serves as a Business Systems Architect at Mundipharma since February 2023, focusing on governance, compliance, and architecture. Responsibilities include chairing the Architectural Review Board, contributing to cyber security initiatives, participating in major ERP implementations, and refining procurement processes. Previously, René held the position of Enterprise Architect at Cambridge University Press, leading architecture efforts for critical business solutions. Additional experience includes project management support for the Oracle R12 upgrade at the University of Cambridge, innovation analysis at CITB, and consulting roles that improved government and business strategies. René's professional journey began with a strong foundation in finance systems analysis and quality management at Motorola, where various roles were undertaken. Educational qualifications include a Master’s degree in Automation and Robotics from the Czech University of Life Sciences Prague.
This person is not in any teams
This person is not in any offices
Mundipharma
5 followers
The Mundipharma global network of independent associated companies shares a common purpose to identify and accelerate the development of meaningful medicines that add value for patients and healthcare providers around the globe. Founded in the US by two physicians in 1952 and still privately owned, the network has a presence in over 120 countries. In Europe, the network employees more than 2,000 employees from R&D to manufacturing & supply and commercial, and with revenues in excess of €1 billion. At Mundipharma we strive for one high performing and learning environment where individuals can make a real difference. We have a strong track record of building successful alliances to license, develop and market medicines that improve patients’ lives, while also providing attractive options to financially constrained healthcare systems. Consistent with our entrepreneurial heritage, we like to think that we see what others don’t by challenging conventional wisdom and asking different and challenging questions. By working in partnership with all our stakeholders, the Mundipharma network develops medicines that create value for patients, payers and wider healthcare systems. We have built a European portfolio of medicines to create value for patients, payers and wider healthcare systems across important therapeutic areas such as diabetes, respiratory, oncology, pain and biosimilars.